David Wiest, PhD, Named to National Cancer Institute’s Board of Scientific Counselors for Basic Sciences

David Weist, PhD

PHILADELPHIA (October 25, 2017) – David Wiest, PhD, deputy chief scientific officer and co-leader of blood cell development and function at Fox Chase Cancer Center, has been appointed to the National Cancer Institute’s Board of Scientific Counselors for Basic Sciences.

The National Cancer Institute (NCI) at the National Institutes of Health continues to remain an important source of funding, supporting universities and cancer centers through grants in addition to supporting its own research facilities. Composed of members knowledgeable across a wide variety of fields, the Board of Scientific Counselors helps the NCI continue its tradition of supporting quality scientific research. Through site visits and evaluations of laboratories and research programs, the board advises the NCI on the future and direction of intramural research programs.

“It’s an important process to make sure that the tradition of excellence continues and resources are used wisely,” Wiest said. “I am honored to be part of the group chosen to help uphold this practice.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427